Cargando…

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

Many factors must be considered and discussed with women when initiating a contraceptive method and the risk of venous thromboembolism (VTE) is one of them. In this review, we discuss the numerous strategies that have been implemented to reduce the thrombotic risk associated with combined oral contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morimont, Laure, Haguet, Hélène, Dogné, Jean-Michel, Gaspard, Ulysse, Douxfils, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697849/ https://www.ncbi.nlm.nih.gov/pubmed/34956081 http://dx.doi.org/10.3389/fendo.2021.769187

Ejemplares similares

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

Hormonal therapies and venous thrombosis: Estrogen matters!
por: Morimont, Laure, et al.
Publicado: (2023)

Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system
por: Morimont, Laure, et al.
Publicado: (2022)

Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
por: Morimont, Laure, et al.
Publicado: (2021)

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
por: Haguet, Hélène, et al.
Publicado: (2020)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
por: Haguet, Hélène, et al.
Publicado: (2018)

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study
por: Haguet, Hélène, et al.
Publicado: (2020)

Estimate of Venous Thromboembolism and Related-Deaths Attributable to the Use of Combined Oral Contraceptives in France
por: Tricotel, Aurore, et al.
Publicado: (2014)

Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
por: Jang, Yong-Su, et al.
Publicado: (2021)

The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On
por: Abdalvand, Ali
Publicado: (2014)

Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study
por: Zöller, Bengt, et al.
Publicado: (2015)

The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
por: Siriez, Romain, et al.
Publicado: (2022)

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
por: Madigan, David, et al.
Publicado: (2018)

First venous thromboembolism and hormonal contraceptives in young French women
por: Hugon-Rodin, Justine, et al.
Publicado: (2017)

Systemic hormonal contraception and risk of venous thromboembolism
por: Heikinheimo, Oskari, et al.
Publicado: (2022)

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle
por: Hampson, Elizabeth, et al.
Publicado: (2022)

Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2015)

The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis
por: Baratloo, Alireza, et al.
Publicado: (2014)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays
por: Douxfils, Jonathan, et al.
Publicado: (2014)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
por: Morimont, Laure, et al.
Publicado: (2022)

Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis
por: Wagner, Jeffrey, et al.
Publicado: (2019)

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations
por: Douxfils, Jonathan, et al.
Publicado: (2015)

Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case–control studies using the QResearch and the CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2014)

Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives
por: Ferreira, Júnia Raquel Dutra, et al.
Publicado: (2017)

No Differences in Value-Based Decision-Making Due to Use of Oral Contraceptives
por: Lewis, Carolin A., et al.
Publicado: (2022)

Morphologic alterations of the fear circuitry: the role of sex hormones and oral contraceptives
por: Brouillard, Alexandra, et al.
Publicado: (2023)

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
por: Favresse, Julien, et al.
Publicado: (2021)

Hormonal contraception and risk of venous thromboembolism: national follow-up study
por: Lidegaard, Øjvind, et al.
Publicado: (2009)

Impact of functional inorganic nanotubes f-INTs-WS(2) on hemolysis, platelet function and coagulation
por: Laloy, Julie, et al.
Publicado: (2018)

Risk prediction of developing venous thrombosis in combined oral contraceptive users
por: McDaid, Aaron, et al.
Publicado: (2017)

Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application
por: Douxfils, Jonathan, et al.
Publicado: (2019)

The Effect of Estetrol/Drospirenone on Ovarian Function Is Similar to a Well-Established Combined Oral Contraceptive: Results From a Phase 2 Study
por: Duijkers, Ingrid J M, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Contraceptive advice during COVID-19 pandemic and the overlapping threat of venous thromboembolism
por: Panda, Soumya Ranjan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1gldtikvaju7qds1inefvhov3a